Reporting Ultrasound Studies
Structures ultrasound interpretation with measurement protocols and ACR guidelines.
Why This Skill Exists
Ultrasound is the primary imaging modality for obstetric evaluation, thyroid assessment, testicular pathology, hepatobiliary disease, and vascular studies. Unlike CT or MRI, ultrasound is operator-dependent — the quality of the study depends heavily on the sonographer's technique. The interpreting radiologist must assess both the sonographic findings and study completeness. ACR Practice Parameters mandate that reports include specific measurement protocols per organ system, standardized terminology (e.g., TI-RADS for thyroid nodules), and explicit technical-adequacy statements. Failure to apply standardized classification systems or recommend appropriate follow-up is a documented source of diagnostic error and malpractice liability.
The real-time, dynamic nature of ultrasound means that subtle findings may only be captured in select images. Reports must distinguish between findings visualized on stored images versus findings noted during real-time scanning, and should explicitly document when a region was not adequately visualized due to body habitus, bowel gas, or patient cooperation.
Checkpoint A: Pre-Draft Intake (Mandatory)
- What type of ultrasound study is being interpreted? (Default: Abdominal — specify: thyroid, pelvic, obstetric, vascular, renal, testicular, breast, MSK)
- What is the clinical indication? (Default: Replace with actual indication from requisition)
- Are prior ultrasound studies available? (Default: No priors)
- Were Doppler images obtained? (Default: Yes, color and spectral Doppler included)
- Is this a screening or diagnostic study? (Default: Diagnostic)
- Are there known lesions requiring follow-up measurement? (Default: No)
- Was the study limited by patient factors (body habitus, bowel gas, non-fasting)? (Default: No limitations)
Documents to Request
- All static ultrasound images with annotations
- Cine clips (when available in PACS)
- Doppler waveform images with velocity measurements
- Sonographer worksheets with measurements
- Prior ultrasound reports and images for comparison
- Relevant lab values (hCG for OB, AFP/liver function for hepatic, TSH for thyroid)
- Requisition with clinical indication
Step 1: Technical Assessment and Study Completeness
Verify that required views per ACR practice parameters are included.
Abdominal Ultrasound — Required Views
- Liver: right lobe (sagittal and transverse), left lobe, dome
- Gallbladder: long axis and transverse; wall thickness; CBD measurement
- Pancreas: head, body, tail (or note if obscured by gas)
- Kidneys: bilateral long axis with measurement; cortical thickness
- Spleen: long axis with measurement
- Aorta: proximal, mid, distal with AP diameter
Thyroid Ultrasound — Required Views
- Each lobe: transverse and longitudinal with three-dimension measurements
- Isthmus: AP measurement
- Nodules: three dimensions, echogenicity, composition, margins, calcifications
- Regional lymph nodes: levels III, IV, VI
Pelvic Ultrasound — Required Views
- Uterus: sagittal and transverse with dimensions; endometrial thickness
- Ovaries: bilateral with dimensions and volume calculation
- Adnexae: cul-de-sac for free fluid
- Transvaginal images when transabdominal is limited
Document any views not obtained and the reason (e.g., "Pancreatic tail not visualized due to overlying bowel gas").
Step 2: Organ-Specific Interpretation
Thyroid — ACR TI-RADS Classification (2017)
Score each nodule using the five TI-RADS categories:
| Feature |
0 Points |
1 Point |
2 Points |
3 Points |
| Composition |
Cystic/spongiform |
Mixed cystic-solid |
Solid or almost solid |
— |
| Echogenicity |
Anechoic |
Hyper/isoechoic |
Hypoechoic |
Very hypoechoic |
| Shape |
Wider than tall |
— |
Taller than wide |
— |
| Margin |
Smooth |
— |
Irregular |
Extra-thyroidal extension |
| Echogenic foci |
None/large comet-tail |
— |
Macrocalcifications |
Punctate echogenic foci |
| TI-RADS Level |
Points |
FNA Threshold |
Follow-up Threshold |
| TR1 — Benign |
0 |
No FNA |
No follow-up |
| TR2 — Not Suspicious |
2 |
No FNA |
No follow-up |
| TR3 — Mildly Suspicious |
3 |
≥2.5 cm |
≥1.5 cm |
| TR4 — Moderately Suspicious |
4–6 |
≥1.5 cm |
≥1.0 cm |
| TR5 — Highly Suspicious |
≥7 |
≥1.0 cm |
≥0.5 cm |
Hepatobiliary
- Liver echogenicity: normal, increased (fatty infiltration), coarsened (cirrhosis)
- Gallbladder wall: <3 mm normal; document stones, polyps, sludge
- CBD: <7 mm (or <10 mm post-cholecystectomy); measure at porta hepatis
- Portal vein: diameter, flow direction, velocity
Renal
- Kidney length: 9–12 cm adult normal
- Cortical thickness: >1 cm normal
- Hydronephrosis grading: mild, moderate, severe (SFU system for pediatric)
- Renal masses: Bosniak classification applicable; document vascularity on Doppler
Step 3: Doppler Evaluation
| Study Type |
Key Measurements |
Normal Values |
| Carotid duplex |
ICA PSV, EDV, ICA/CCA ratio |
<125 cm/s PSV = <50% stenosis |
| Renal artery |
PSV, RI, acceleration time |
RI 0.55–0.70; AT <70 ms |
| Hepatic |
Portal vein velocity and direction |
15–40 cm/s, hepatopetal |
| DVT lower extremity |
Compressibility, augmentation, spectral waveform |
Full compressibility, phasic flow |
| Testicular |
Intratesticular flow symmetry |
Symmetric arterial flow bilaterally |
Always report spectral waveform pattern (low vs. high resistance), velocity values, and any reversal of flow.
Step 4: Report Structure
Header
- Patient demographics, study date, accession
- Examination type (e.g., "Complete abdominal ultrasound with Doppler")
- Clinical indication
Comparison
- Prior ultrasound studies with dates; note modality differences (e.g., prior CT comparison)
Technique
- Transducer type and frequency (if available)
- Scanning approach (transabdominal, transvaginal, both)
- Fasting status for hepatobiliary studies
- Technical limitations
Findings
- Organ-by-organ in standard order
- Each finding: location → sonographic characteristics → dimensions → Doppler findings → change from prior
Impression
- Numbered, clinically significant findings first
- Classification assignments (TI-RADS, Bosniak, etc.)
- Specific follow-up recommendations with timing and modality
Step 5: Follow-Up Recommendations
Always specify follow-up per relevant classification system or ACR Incidental Findings Committee.
| Finding |
Recommendation |
| TI-RADS 3 nodule ≥1.5 cm |
Follow-up US in 1, 3, 5 years |
| TI-RADS 4 nodule ≥1.5 cm |
FNA recommended |
| Simple hepatic cyst |
No follow-up |
| Complex ovarian cyst, premenopausal |
Repeat US in 6–12 weeks |
| Gallbladder polyp >10 mm |
Cholecystectomy referral |
| Gallbladder polyp 6–9 mm |
US in 6 months, then annually |
| Abdominal aortic aneurysm 3.0–3.9 cm |
Repeat US in 12 months |
| AAA 4.0–5.4 cm |
Repeat US in 6 months |
Checkpoint B: Post-Draft Alignment (Mandatory)
- Are all required views documented or limitations noted?
- Are classification systems (TI-RADS, Bosniak) correctly applied with all scoring features?
- Do Doppler measurements include actual velocity values?
- Are follow-up recommendations specific with timing and modality?
- Is the impression addressing the clinical question directly?
Quality Audit
Guidelines
- Always document study completeness — ultrasound is operator-dependent and incomplete studies require explicit notation.
- Apply ACR TI-RADS with itemized feature scores; do not assign a TI-RADS level without documenting each criterion.
- Report Doppler values numerically — qualitative descriptors like "normal flow" are insufficient.
- Measure the CBD at the porta hepatis consistently; document whether the patient was fasting.
- For obstetric ultrasound, follow AIUM Practice Parameters for gestational age assessment, anatomy survey completeness, and biometric measurements.
- When body habitus limits evaluation, recommend alternative imaging (CT or MRI) rather than simply noting the limitation.
- Classify ovarian lesions using the O-RADS system when applicable, including risk stratification and management recommendation.
1---2name: reporting-ultrasound-studies3description: Structures ultrasound interpretation with measurement protocols and ACR guidelines. Use when reading ultrasound exams, documenting sonographic findings, or creating US reports.4---5
6# Reporting Ultrasound Studies
7
8Structures ultrasound interpretation with measurement protocols and ACR guidelines.
9
10## Why This Skill Exists
11
12Ultrasound is the primary imaging modality for obstetric evaluation, thyroid assessment, testicular pathology, hepatobiliary disease, and vascular studies. Unlike CT or MRI, ultrasound is operator-dependent — the quality of the study depends heavily on the sonographer's technique. The interpreting radiologist must assess both the sonographic findings and study completeness. ACR Practice Parameters mandate that reports include specific measurement protocols per organ system, standardized terminology (e.g., TI-RADS for thyroid nodules), and explicit technical-adequacy statements. Failure to apply standardized classification systems or recommend appropriate follow-up is a documented source of diagnostic error and malpractice liability.
13
14The real-time, dynamic nature of ultrasound means that subtle findings may only be captured in select images. Reports must distinguish between findings visualized on stored images versus findings noted during real-time scanning, and should explicitly document when a region was not adequately visualized due to body habitus, bowel gas, or patient cooperation.
15
16---
17
18## Checkpoint A: Pre-Draft Intake (Mandatory)
19
201. **What type of ultrasound study is being interpreted?** (Default: Abdominal — specify: thyroid, pelvic, obstetric, vascular, renal, testicular, breast, MSK)
212. **What is the clinical indication?** (Default: Replace with actual indication from requisition)
223. **Are prior ultrasound studies available?** (Default: No priors)
234. **Were Doppler images obtained?** (Default: Yes, color and spectral Doppler included)
245. **Is this a screening or diagnostic study?** (Default: Diagnostic)
256. **Are there known lesions requiring follow-up measurement?** (Default: No)
267. **Was the study limited by patient factors (body habitus, bowel gas, non-fasting)?** (Default: No limitations)
27
28### Documents to Request
29
30- All static ultrasound images with annotations
31- Cine clips (when available in PACS)
32- Doppler waveform images with velocity measurements
33- Sonographer worksheets with measurements
34- Prior ultrasound reports and images for comparison
35- Relevant lab values (hCG for OB, AFP/liver function for hepatic, TSH for thyroid)
36- Requisition with clinical indication
37
38---
39
40## Step 1: Technical Assessment and Study Completeness
41
42Verify that required views per ACR practice parameters are included.
43
44### Abdominal Ultrasound — Required Views
45- Liver: right lobe (sagittal and transverse), left lobe, dome
46- Gallbladder: long axis and transverse; wall thickness; CBD measurement
47- Pancreas: head, body, tail (or note if obscured by gas)
48- Kidneys: bilateral long axis with measurement; cortical thickness
49- Spleen: long axis with measurement
50- Aorta: proximal, mid, distal with AP diameter
51
52### Thyroid Ultrasound — Required Views
53- Each lobe: transverse and longitudinal with three-dimension measurements
54- Isthmus: AP measurement
55- Nodules: three dimensions, echogenicity, composition, margins, calcifications
56- Regional lymph nodes: levels III, IV, VI
57
58### Pelvic Ultrasound — Required Views
59- Uterus: sagittal and transverse with dimensions; endometrial thickness
60- Ovaries: bilateral with dimensions and volume calculation
61- Adnexae: cul-de-sac for free fluid
62- Transvaginal images when transabdominal is limited
63
64Document any views not obtained and the reason (e.g., "Pancreatic tail not visualized due to overlying bowel gas").
65
66---
67
68## Step 2: Organ-Specific Interpretation
69
70### Thyroid — ACR TI-RADS Classification (2017)
71
72Score each nodule using the five TI-RADS categories:
73
74| Feature | 0 Points | 1 Point | 2 Points | 3 Points |
75|---------|----------|---------|----------|----------|
76| **Composition** | Cystic/spongiform | Mixed cystic-solid | Solid or almost solid | — |
77| **Echogenicity** | Anechoic | Hyper/isoechoic | Hypoechoic | Very hypoechoic |
78| **Shape** | Wider than tall | — | Taller than wide | — |
79| **Margin** | Smooth | — | Irregular | Extra-thyroidal extension |
80| **Echogenic foci** | None/large comet-tail | — | Macrocalcifications | Punctate echogenic foci |
81
82| TI-RADS Level | Points | FNA Threshold | Follow-up Threshold |
83|---------------|--------|---------------|---------------------|
84| TR1 — Benign | 0 | No FNA | No follow-up |
85| TR2 — Not Suspicious | 2 | No FNA | No follow-up |
86| TR3 — Mildly Suspicious | 3 | ≥2.5 cm | ≥1.5 cm |
87| TR4 — Moderately Suspicious | 4–6 | ≥1.5 cm | ≥1.0 cm |
88| TR5 — Highly Suspicious | ≥7 | ≥1.0 cm | ≥0.5 cm |
89
90### Hepatobiliary
91- Liver echogenicity: normal, increased (fatty infiltration), coarsened (cirrhosis)
92- Gallbladder wall: <3 mm normal; document stones, polyps, sludge
93- CBD: <7 mm (or <10 mm post-cholecystectomy); measure at porta hepatis
94- Portal vein: diameter, flow direction, velocity
95
96### Renal
97- Kidney length: 9–12 cm adult normal
98- Cortical thickness: >1 cm normal
99- Hydronephrosis grading: mild, moderate, severe (SFU system for pediatric)
100- Renal masses: Bosniak classification applicable; document vascularity on Doppler
101
102---
103
104## Step 3: Doppler Evaluation
105
106| Study Type | Key Measurements | Normal Values |
107|-----------|-----------------|---------------|
108| Carotid duplex | ICA PSV, EDV, ICA/CCA ratio | <125 cm/s PSV = <50% stenosis |
109| Renal artery | PSV, RI, acceleration time | RI 0.55–0.70; AT <70 ms |
110| Hepatic | Portal vein velocity and direction | 15–40 cm/s, hepatopetal |
111| DVT lower extremity | Compressibility, augmentation, spectral waveform | Full compressibility, phasic flow |
112| Testicular | Intratesticular flow symmetry | Symmetric arterial flow bilaterally |
113
114Always report spectral waveform pattern (low vs. high resistance), velocity values, and any reversal of flow.
115
116---
117
118## Step 4: Report Structure
119
120### Header
121- Patient demographics, study date, accession
122- Examination type (e.g., "Complete abdominal ultrasound with Doppler")
123- Clinical indication
124
125### Comparison
126- Prior ultrasound studies with dates; note modality differences (e.g., prior CT comparison)
127
128### Technique
129- Transducer type and frequency (if available)
130- Scanning approach (transabdominal, transvaginal, both)
131- Fasting status for hepatobiliary studies
132- Technical limitations
133
134### Findings
135- Organ-by-organ in standard order
136- Each finding: location → sonographic characteristics → dimensions → Doppler findings → change from prior
137
138### Impression
139- Numbered, clinically significant findings first
140- Classification assignments (TI-RADS, Bosniak, etc.)
141- Specific follow-up recommendations with timing and modality
142
143---
144
145## Step 5: Follow-Up Recommendations
146
147Always specify follow-up per relevant classification system or ACR Incidental Findings Committee.
148
149| Finding | Recommendation |
150|---------|---------------|
151| TI-RADS 3 nodule ≥1.5 cm | Follow-up US in 1, 3, 5 years |
152| TI-RADS 4 nodule ≥1.5 cm | FNA recommended |
153| Simple hepatic cyst | No follow-up |
154| Complex ovarian cyst, premenopausal | Repeat US in 6–12 weeks |
155| Gallbladder polyp >10 mm | Cholecystectomy referral |
156| Gallbladder polyp 6–9 mm | US in 6 months, then annually |
157| Abdominal aortic aneurysm 3.0–3.9 cm | Repeat US in 12 months |
158| AAA 4.0–5.4 cm | Repeat US in 6 months |
159
160---
161
162## Checkpoint B: Post-Draft Alignment (Mandatory)
163
1641. Are all required views documented or limitations noted?
1652. Are classification systems (TI-RADS, Bosniak) correctly applied with all scoring features?
1663. Do Doppler measurements include actual velocity values?
1674. Are follow-up recommendations specific with timing and modality?
1685. Is the impression addressing the clinical question directly?
169
170---
171
172## Quality Audit
173
174- [ ] Study completeness is assessed (all required views per ACR)
175- [ ] Technical limitations are explicitly documented
176- [ ] Each visualized organ includes dimensions where applicable
177- [ ] TI-RADS scoring shows individual feature scores and total points
178- [ ] Doppler evaluations include numeric velocity values (not just "normal")
179- [ ] Gallbladder wall thickness and CBD diameter are measured
180- [ ] Renal length and cortical thickness are documented bilaterally
181- [ ] Liver echogenicity is characterized relative to renal cortex
182- [ ] Classification systems are applied with management recommendations
183- [ ] Prior comparisons referenced with specific dates
184- [ ] Impression items are numbered and clinically prioritized
185- [ ] Non-visualized structures are documented with reason
186- [ ] Fasting status noted for hepatobiliary exams
187- [ ] Laterality is explicit for all paired organs
188
189---
190
191## Guidelines
192
1931. Always document study completeness — ultrasound is operator-dependent and incomplete studies require explicit notation.
1942. Apply ACR TI-RADS with itemized feature scores; do not assign a TI-RADS level without documenting each criterion.
1953. Report Doppler values numerically — qualitative descriptors like "normal flow" are insufficient.
1964. Measure the CBD at the porta hepatis consistently; document whether the patient was fasting.
1975. For obstetric ultrasound, follow AIUM Practice Parameters for gestational age assessment, anatomy survey completeness, and biometric measurements.
1986. When body habitus limits evaluation, recommend alternative imaging (CT or MRI) rather than simply noting the limitation.
1997. Classify ovarian lesions using the O-RADS system when applicable, including risk stratification and management recommendation.